Abstract:P>MicroRNAs (miRNAs) play essential roles in many biological processes. It is known that aberrant miRNA expression contributes to some pathological conditions. However, it is not known whether miRNAs play any role in the development of insulin resistance in adipocytes, a key pathophysiological link between obesity and diabetes. To investigate the function of miRNAs in the development of insulin resistance, using miRNA microarray analysis we compared miRNA expression profiles between normal insulin-sensitive 3T3-L1 adipocytes and 3T3-L1 adipocytes rendered insulin resistant following treatment with high glucose (25 mmol/L) and high insulin (1 mu mol/L). Furthermore, adipocytes were transfected with specific antisense oligonucleotides against miRNA-320 (anti-miR-320 oligo) and the effects on the development of insulin resistance were evaluated. We identified 50 upregulated and 29 downregulated miRNAs in insulin-resistant (IR) adipocytes, including a 50-fold increase in miRNA-320 (miR-320) expression. Using bioinformatic techniques, the p85 subunit of phosphatidylinositol 3-kinase (PI3-K) was found to be a potential target of miR-320. In experiments with anti-miR-320 oligo, insulin sensitivity was increased in IR adipocytes, as evidenced by increases in p85 expression, phosphorylation of Akt and the protein expression of the glucose transporter GLUT-4, as well as insulin-stimulated glucose uptake. These beneficial effects of anti-miR-320 oligo were observed only in IR adipocytes and not in normal adipocytes. In conclusion, the miRNA profile changes in IR adipocytes compared with normal 3T3-L1 adipocytes. Anti-miR-320 oligo was found to regulate insulin resistance in adipocytes by improving insulin-PI3-K signalling pathways. The findings provide information regarding a potentially new therapeutic strategy to control insulin resistance.

miR-222 exerts negative regulation on insulin signaling pathway in 3T3-L1 adipocytes

Circulating Mir-143-3p Inhibition Protects Against Insulin Resistance in Metabolic Syndrome Via Targeting of the Insulin-Like Growth Factor 2 Receptor.

MiR-221/222 inhibit insulin production of pancreatic β-cells in mice.

MicroRNA-223 is Essential for Maintaining Functional Β-Cell Mass During Diabetes Through Inhibiting Both FOXO1 and SOX6 Pathways

Mir-10B-5p Regulates 3T3-L1 Cells Differentiation by Targeting Apol6.

MiR-224 impairs adipocyte early differentiation and regulatesfatty acid metabolism

CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes.

[Mir-494-3p Reduces Insulin Sensitivity in Diabetic Cardiomyocytes by Down-Regulation of Insulin Receptor Substrate 1].

MicroRNA-26a Regulates Insulin Sensitivity and Metabolism of Glucose and Lipids.

Mir-152 Regulates 3T3-L1 Preadipocyte Proliferation and Differentiation

MicroRNA‐139‐5p Suppresses 3T3‐L1 Preadipocyte Differentiation Through Notch and IRS1/PI3K/Akt Insulin Signaling Pathways

MicroRNA-204-5p Regulates 3T3-L1 Preadipocyte Proliferation, Apoptosis and Differentiation

Lower miR-26a levels in breastmilk affect gene expression in adipose tissue of offspring

miR‐221 negatively regulates inflammation and insulin sensitivity in white adipose tissue by repression of sirtuin‐1 (SIRT1)

Mir-144-3p Promotes Adipogenesis Through Releasing C/EBPα from Klf3 and CtBP2

MiR‐25 Suppresses 3T3‐L1 Adipogenesis by Directly Targeting KLF4 and C/EBPα

MicroRNA-125a-5p Mediates 3T3-L1 Preadipocyte Proliferation and Differentiation

Gonadal White Adipose Tissue-Derived Exosomal Mir-222 Promotes Obesity-Associated Insulin Resistance

miR-128-3p regulates 3T3-L1 adipogenesis and lipolysis by targeting Pparg and Sertad2

MicroRNA-215 Impairs Adipocyte Differentiation and Co-Represses FNDC3B and CTNNBIP1

MicroRNA-425 Controls Lipogenesis and Lipolysis in Adipocytes.